Advertisement
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

0
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
More than a third of colorectal cancers diagnosed in younger patients are caused by inherited gene mutations

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic

0
Study authors recommend that people diagnosed before age 35 get tested
A new diagnostic to differentiate between HIV-1 antibodies

FDA Approves Test to Differentiate HIV Viruses

0
Among people two years and older
Eradication of Helicobacter pylori in asymptomatic adults is associated with a reduction in the incidence of gastric cancer

Review: Eradicating H. pylori Cuts Incidence of Gastric Cancer

0
Reduction in the incidence of gastric cancer with tx of asymptomatic, otherwise healthy individuals
As a result of the increasing popularity of high-deductible health care plans

Expansion of High-Deductible Plans to Impact Physician Care

0
Physicians must be able to balance provision of good clinical care with ability to limit costs
Researchers say they've made preliminary progress toward developing a drug that one day may treat people infected with the Marburg virus

Progress Reported in Treatment of Marburg Virus

0
Researchers found infected monkeys were less likely to die with treatment
Cellular damage occurs when people undergo computed tomography scans

Evidence of Cellular Damage From Computed Tomography

0
But whether this could trigger cancer or other health issues remains unclear
Stillbirths have eclipsed infant deaths for the first time in the United States

CDC: Stillbirths Now Outnumber Infant Deaths in U.S.

0
Experts point to dropping infant death rates, racial disparities in care, and fertility treatments as factors
A drug called solanezumab may slow Alzheimer's disease progression by about one-third

AAIC: Hints That New Drug May Slow Alzheimer’s Progression

0
Initial findings need to be supported by additional studies
Taking two 12-week courses of alefacept -- a drug already approved to treat psoriasis -- may help people with newly diagnosed type 1 diabetes mellitus preserve pancreatic β-cell function

Psoriasis Med May Help Preserve Pancreas Function in Type 1 DM

0
Used early after diagnosis, medication appears to have long-lasting effects